About Us

Endovascular Engineering, Inc. (“E2”), is a mission-driven, venture-backed company focused on the development and deployment of next generation clot removal technologies that target venous thromboembolism.

COMPANY VISION

OUR TEAM

Endovascular Engineering (“E2”) is led by an experienced team of engineers, clinicians, and medical device leaders with decades of experience and a proven track record in developing and commercializing endovascular technologies. In collaboration with leading clinical partners, we are dedicated to advancing the treatment of venous thromboembolism and improving outcomes for patients.

Leadership Team

Dan Rose
Dan Rose
Chief Executive Officer
Thomas Engels
Thomas Engels
Chief Operating Officer
Scott Baron
Scott Baron
Chief Technology Officer
Justin Farry
Justin Farry
Chief Financial Officer
Luis Savastano, MD, PhD
Luis Savastano, MD, PhD
Founder, Chief Scientific Officer
Mike Rosenthal
Mike Rosenthal
Head of Innovation
Shane Johnson
Shane Johnson
SVP of Sales
Debra Cogan
Debra Cogan
VP of Clinical and Regulatory Affairs
Keri Ng
Keri Ng
VP of Quality
Dave Snow
Dave Snow
VP of Research and Development
Torsten Kimura
Torsten Kimura
VP of Manufacturing Operations
Lee Pusateri
Lee Pusateri
VP of Marketing

Key Clinical Partners

Eric Secemsky, MD, MSc
Eric Secemsky, MD, MSc
Interventional Cardiology
Jay Giri, MD, MPH
Jay Giri, MD, MPH
Interventional Cardiology
Andrew Klein, MD
Andrew Klein, MD
Interventional Cardiology
Julie Bulman, MD
Julie Bulman, MD
Interventional Radiology
Kush Desai, MD
Kush Desai, MD
Interventional Radiology

Want to join our team? Explore Career Opportunities